Correction to: Scientific Reports https://doi.org/10.1038/s41598-025-90805-7, published online 21 February 2025
In the original version of the Article, Figure 3f was a duplication of Figure 4e.
The original Figure 3 and accompanying legend appear below.
Therapeutic effect of gelADSC after hepatectomy for normal liver. (a) Intraoperative photograph showing gelADSC placed on the surface of the remnant liver (black arrows). (b) The liver to body weight ratio was significantly higher on POD 2 in the gelADSC group than in the control group. (c) Representative images of the histological evaluation of remnant liver showing the accumulation of lipid in the control group on H&E staining, whereas such accumulation is decreased in the ivADSC and gelADSC groups. Immunohistochemistry for PCNA showed a significant increase in PCNA-positive cells in the gelADSC group compared with the control group. Scale bar = 100 μm. (d) A triglyceride assay revealed that the liver triglyceride content in the gelADSC group was significantly higher than in the control group but comparable to the ivADSC group. The cholesterol content was comparable between the three groups. (e) mRNA expression in the liver was evaluated by real-time PCR. The expression of Acc, Fasn, and Srebp-1c was comparable between the three groups, whereas that of Cpt-1a, Crot, and Pparα was significantly upregulated in the gelADSC group, the ivADSC group, and the control group in that order. (f) The liver to body weight ratio on POD 2 was comparable between the gelADSC group and the ivADSC group. *p < 0.05.
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Imamura, H., Tomimaru, Y., Kobayashi, S. et al. Author Correction: Adipose-derived stem cells using fibrin gel as a scaffold enhances post-hepatectomy liver regeneration. Sci Rep 15, 16454 (2025). https://doi.org/10.1038/s41598-025-99702-5
Published:
DOI: https://doi.org/10.1038/s41598-025-99702-5
